prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
correspondence Address:
Jihlavská 340/20, 625 00 Brno
| phone: | +420 532 23 2144, 3603 |
|---|---|
| e‑mail: |
|
| social and academic networks: |
|---|
Total number of publications: 871
2006
-
Rituximab Senzitizes B-CLL Cells with Inactived p53 to fludarabine
Year: 2006, type: Conference abstract
-
Role of p53 Gene Mutation Type in B-CLL Prognosis
Year: 2006, type: R&D Presentation
-
Splenektomie v diagnostice a léčbě hematologických onemocnění - indikace, komplikace a výsledky z jednoho pracoviště
Transfuze a hematologie dnes, year: 2006, volume: 12, edition: 3
-
Srovnání kontinuální infuse a bolusové aplikace mononukleárních buněk kostní dřeně do koronárních arterií při infarktu myokardu.
Year: 2006, type: Conference abstract
-
Srovnání kontinuální infuse a bolusové intrakoronární aplikace značených mononukleárních buněk v modelu akutního infarktu myokardu u prasete.
Year: 2006, type: Conference abstract
2005
-
Acute myeloid leukemia treatment patients over 60 years of age. Comparision of sympromatic, palliative, and aggressive therapy
Neoplasma, year: 2005, volume: 52, edition: 2
-
Acute myeloid leukemias with reccurent genetic abnormalities: frequent assessment of minimal residual disease and treatment of molecular relaps with chemotherapy. Acute myeloid leukemias with reccurent genetic abnormalities: frequent assessment of minima
Leukemia, year: 2005, volume: 19, edition: 5
-
Alemtuzumab v léčbě pacientů s chronickou lymfatickou leukémií.
Postgraduální onkologie, year: 2005, volume: 1, edition: 1
-
Analysis of p53 protein in patiens with B-cell chronic lymphocytic leukemia.
Year: 2005, type: Conference abstract
-
Expression analysis of B-CLL cells with different IgVH status and presence or absence of 13q14 deletion.
Year: 2005, type: Conference abstract